Effect of panlong needling at Jiaji (EX-B 2) on motor dysfunction in patients with Parkinson's disease of liver and kidney deficiency: a randomized controlled trial.
10.13703/j.0255-2930.20210605-0001
- Author:
Lin HAN
1
;
Xiu-Zhen SU
2
,
3
;
Zhong-Yuan ZHANG
4
;
Ying LIU
4
;
Zhong-Xiang WEI
1
;
Qing-Lan ZHANG
1
;
Jun-Ping ZHANG
1
;
Chen-Xi WANG
4
;
Quan-de SU
4
Author Information
1. College of Acupuncture-Moxibustion and Tuina, Shandong University of TCM, Jinan 250355,China.
2. College of Acupuncture-Moxibustion and Tuina, Shandong University of TCM, Jinan 250355,China
3. Department of Acupuncture and Moxibustion, Weifang Hospital of TCM, Weifang 261041, Shandong Province.
4. Department of Acupuncture and Moxibustion, Weifang Hospital of TCM, Weifang 261041, Shandong Province.
- Publication Type:Randomized Controlled Trial
- Keywords:
Parkinson's disease;
Point EX-B 2 (Jiaji);
motor dysfunction;
panlong needling;
randomized controlled trial (RCT)
- MeSH:
Acupuncture Points;
Acupuncture Therapy;
Chlorophenols;
Humans;
Kidney;
Liver;
Parkinson Disease/therapy*;
Quality of Life;
Treatment Outcome
- From:
Chinese Acupuncture & Moxibustion
2022;42(5):493-497
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the curative effect of panlong needling at Jiaji (EX-B 2) combined with western medication and western medication alone on motor dysfunction in patients with Parkinson's disease (PD) of liver and kidney deficiency.
METHODS:A total of 98 patients with PD were randomly divided into an acupuncture and medication group (49 cases, 1 case dropped off) and a western medication group (49 cases,1 case was removed). The patients in the western medication group were given oral of levodopa and benserazide hydrochloride tablets, 125 mg each time, three times a day in the 1st week, and the dose was increased according to the needs of the patients' condition from the 2nd week until 250 mg each time, three times a day, for 16 consecutive weeks. On the basis of the same western medication treatment as the western medication group, panlong needling was applied at Jiaji (EX-B 2) from C2 to L5 in the acupuncture and medication group, once a day, 20 times as a course of treatment, for 4 consecutive courses. The scores of unified Parkinson's disease rating scale (UPDRS-Ⅲ, UPDRS-Ⅳ), TCM symptoms score, and 39-item Parkinson's disease questionnaire (PDQ-39) score were evaluated before treatment, after treatment and during follow-up of 1 month after treatment, respectively. The safety of the two groups was compared.
RESULTS:After treatment and during follow-up, except the PDQ-39 score of the western medication group, the scores of UPDRS-Ⅲ, UPDRS-Ⅳ, TCM syndrome and PDQ-39 were lower than those before treatment in the two groups (P<0.05), and the scores of above indexes in the acupuncture and medication group were lower than those of the western medication group (P<0.05). The total incidence of adverse reactions in the acupuncture and medication group was 10.4% (5/48), which was lower than 29.2% (14/48) in the western medication group (P<0.05).
CONCLUSION:Panlong needling at Jiaji (EX-B 2) combined with western medication could significantly improve the motor dysfunction and clinical symptoms, improve the quality of life and has high safety, and the efficacy is superior to western medication alone.
